TGL Medical Limited 12846166 false 2024-09-01 2025-08-31 2025-08-31 The principal activity of the company is Agents involved in the sale of a variety goods Digita Accounts Production Advanced 6.30.9574.0 true true 12846166 2024-09-01 2025-08-31 12846166 2025-08-31 12846166 bus:OrdinaryShareClass1 2025-08-31 12846166 core:CurrentFinancialInstruments 2025-08-31 12846166 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-31 12846166 bus:SmallEntities 2024-09-01 2025-08-31 12846166 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 12846166 bus:FilletedAccounts 2024-09-01 2025-08-31 12846166 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 12846166 bus:RegisteredOffice 2024-09-01 2025-08-31 12846166 bus:Director2 2024-09-01 2025-08-31 12846166 bus:OrdinaryShareClass1 2024-09-01 2025-08-31 12846166 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 12846166 countries:England 2024-09-01 2025-08-31 12846166 2023-09-01 2024-08-31 12846166 2024-08-31 12846166 bus:OrdinaryShareClass1 2024-08-31 12846166 core:CurrentFinancialInstruments 2024-08-31 12846166 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12846166

TGL Medical Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 August 2025

TGL Medical Limited

Contents

Company Information | 1
Balance Sheet | 2
Notes to the Unaudited Financial Statements | 3 to 5

TGL Medical Limited

Company Information

Director | Mr Clinton John Greaves

Registered office | 71-75 Shelton Street, Covent Garden London WC2H 9JQ

Accountants | M.G. Walker & Co. Limited The Coach House 119a High Street Clay Cross Chesterfield Derbyshire S45 9DZ

TGL Medical Limited

(Registration number: 12846166)
Balance Sheet as at 31 August 2025

| Note | 2025 £ | 2024 £
Current assets |  |  |
Stocks | 4 | - | 40,770
Debtors | 5 | 4,005 | 2,323
Cash at bank and in hand |  | 309 | 4,133
|  | 4,314 | 47,226
Creditors: Amounts falling due within one year | 6 | (37,495) | (74,293)
Net liabilities |  | (33,181) | (27,067)
Capital and reserves |  |  |
Called up share capital | 7 | 10 | 10
Retained earnings |  | (33,191) | (27,077)
Shareholders' deficit |  | (33,181) | (27,067)

For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 13 May 2026

......................................... Mr Clinton John Greaves Director

TGL Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025

1 | General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
71-75 Shelton Street,
Covent Garden
London
WC2H 9JQ
England

These financial statements were authorised for issue by the director on 13 May 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

TGL Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2024 - 0).

4 | Stocks

| 2025 £ | 2024 £
Other inventories | - | 40,770

5 | Debtors

TGL Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025

Current | 2025 £ | 2024 £
Trade debtors | 670 | -
Prepayments | 10 | 10
Other debtors | 3,325 | 2,313
| 4,005 | 2,323

6 | Creditors

Creditors: amounts falling due within one year

| 2025 £ | 2024 £
Due within one year |  |
Accruals and deferred income | 830 | 3,458
Other creditors | 36,665 | 70,835
| 37,495 | 74,293

7 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary shares of £0.01 each | 1,000 | 10 | 1,000 | 10

Allotted, called up and not fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary shares of £0.01 each | 1,000 | 10.00 | 1,000 | 10.00